SCIESCOPUSQ1
Cancer Drug Resistance
OAE PUBLISHING INC, United States
Cancer Drug Resistance is an academic journal published by OAE PUBLISHING INC (United States). Identifiers: eISSN 2578-532X. Indexed in SCIE, SCOPUS. Metrics: JIF 5.2, CiteScore 8.3, SJR 1.495, SNIP 0.92. Subject areas: ONCOLOGY. tlooto lists 558 papers from this journal.
CiteScore
8.30
Scopus citation metric
SJR
1.495
SCImago rank
SNIP
0.92
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2578-532X
- Abbreviation
- CANCER DRUG RESIST
- Publisher
- OAE PUBLISHING INC
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1306 Cancer Research2736 Pharmacology (medical)
Papers in this journal
Recent papers
- Tumor heterogeneity as a driver of drug resistance and its implications for personalized therapy
2026
- Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies
2026
- Adenylosuccinate lyase in pancreatic ductal adenocarcinoma chemoresistance: from purine metabolism to metabolic vulnerability
2026
- Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them
2026
- Divergent transcriptional programs and constrained metabolic states reveal selective metabolic dependencies in chemoresistant luminal breast cancer
2026
Most cited papers
- Drug resistance and combating drug resistance in cancer
2019 · 1,002 citations
- Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
2020 · 430 citations
- Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance
2020 · 139 citations
- Mechanisms of chemotherapy resistance in ovarian cancer
2022 · 111 citations
- Venetoclax resistance: mechanistic insights and future strategies
2022 · 92 citations